Sickle Cell Bet

[stock_market_widget type=”card” template=”basic2″ assets=”FULC” realtime=”true” api=”yahoo-finance”] Fulcrum Therapeutics Inc. (NASDAQ: FULC) is building its long-term investment case around a single oral drug candidate that could...